Saudi Arabia
Partnership signed on the sidelines of Global Health Saudi 2024; aims to drive patient safety, reduce medication errors, and improve healthcare worker safety in line with Vision 2030.
11 November, 2024 – The Saudi entity of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has signed a strategic partnership with the Saudi Patient Safety Center (SPSC) to improve patient safety and healthcare quality across the Kingdom.
The partnership, formalized through a Memorandum of Understanding (MoU) that was signed on the sidelines of the Global Health Exhibition in Saudi Arabia, reinforces a shared commitment from both organizations to support Saudi Vision 2030 by tackling critical healthcare challenges such as reducing medication errors, managing sepsis, and combating Healthcare-associated Infections (HAIs) and Antimicrobial Resistance (AMR). These efforts align with BD Signature Programmes™, which focus on enhancing patient safety, healthcare worker safety, and driving efficiency.
Key areas of focus will include medication safety to achieve zero harm from medication errors, prevention of HAIs such as Central Line-associated Bloodstream Infections (CLABSI), Catheter-associated Urinary Tract Infections (CAUTI), and Surgical Site Infections (SSI). Additionally, the collaboration will emphasize antimicrobial stewardship as well as improve sustainability and workflow efficiency across healthcare systems.
“This collaboration marks a significant step forward in our journey to elevate healthcare safety across the Kingdom,” said Dr. Ali Asery, Director General of the Saudi Patient Safety Center. “By combining our strategic vision with BD’s global expertise and innovative technologies, we aim to foster a culture of continuous improvement in patient and healthcare worker safety. Together, we will set new benchmarks for excellence in alignment with Saudi Vision 2030, and empower healthcare professionals with the tools and knowledge necessary to drive safer, more effective care delivery for our nation.”
The partnership will involve a series of workshops, roundtable discussions, clinical training sessions and exchange of best practices in more than 500 hospitals across the country, as well as the development and sharing of clinical guidelines inspired by international recommendations. The partnership will also focus on improving data collection in full alignment of the Personal Data Protection Law (PDPL) and conducting surveys to gather insights from healthcare professionals across Saudi Arabia. Both organizations will also collaborate on the development of a whitepaper titled ‘Medication Safety 2030,’ advocating for a national strategy to achieve zero harm from medication errors.
Omar Malabarey, Country General Manager BD Saudi Arabia, added, “Our partnership with the Saudi Patient Safety Center marks a significant step forward in our shared commitment to shaping the future of healthcare in Saudi Arabia. At BD, we are deeply invested in transforming patient safety through innovation, and this collaboration enables us to bring world-class expertise and technologies to support the Kingdom’s healthcare goals. By working together, we aim to reduce risks, enhance the quality of care, and foster a culture of safety and continuous improvement, in line with Vision 2030’s aspirations for a sustainable and resilient healthcare system.”
This is intended for Healthcare Professionals only.
BD-138295
-ENDS-
About BD:
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians’ care delivery process, enable laboratory scientists to accurately detect disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson.
For more information (Press only):